Select Publications
Journal articles
2007, 'International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency', European Journal of Cancer, 43, pp. 14 - 34, http://dx.doi.org/10.1016/j.ejca.2006.11.004
,2007, 'Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations', Annals of Oncology, 18, pp. 1314 - 1321, http://dx.doi.org/10.1093/annonc/mdm011
,2006, 'Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study', Gynecologic Oncology, 103, pp. 439 - 445, http://dx.doi.org/10.1016/j.ygyno.2006.03.017
,2006, 'Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.', Cochrane database of systematic reviews (Online), 3
,2006, 'Chemotherapy and radiotherapy for pancreatic cancer', Cochrane Database of Systematic Reviews, 4
,2005, 'Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer', Women's Oncology Review, 5, pp. 109 - 111, http://dx.doi.org/10.1080/14733400500178618
,2005, 'Reply to the letter "Limitations of bedside estimates of renal function", by M. J. Dooley and S. G. Poole', ANNALS OF ONCOLOGY, 16, pp. 990 - 990, http://dx.doi.org/10.1093/annonc/mdi174
,2005, 'Limitations of Wright formula estimates of renal function (multiple letters) [3]', Annals of Oncology, 16, pp. 989 - 990, http://dx.doi.org/10.1093/annonc/mdi173
,2005, 'Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer', The Women's Oncology Review, 5, pp. 109 - 111, http://dx.doi.org/10.3109/14733400500178618
,2004, 'Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with advanced epithelial ovarian cancer. A phase II trial of sequential doublets. (GO-FIRST)', Journal of Clinical Oncology, 22, pp. 5034 - 5034, http://dx.doi.org/10.1200/jco.2004.22.90140.5034
,2004, 'Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with advanced epithelial ovarian cancer. A phase II trial of sequential doublets. (GO-FIRST)', Journal of Clinical Oncology, 22, pp. 5034 - 5034, http://dx.doi.org/10.1200/jco.2004.22.14_suppl.5034
,2004, 'A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer', Women's Oncology Review, 4, pp. 135 - 136, http://dx.doi.org/10.1080/14733400410001728483
,2004, 'Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients', Annals of Oncology, 15, pp. 291 - 295, http://dx.doi.org/10.1093/annonc/mdh079
,2004, 'Recent advances in management of small-cell lung cancer', Cancer Treatment Reviews, 30, pp. 521 - 543
,2003, 'Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: Single-centre experience with long-term follow up', Internal Medicine Journal, 33, pp. 427 - 435, http://dx.doi.org/10.1046/j.1445-5994.2003.00456.x
,2003, 'Poor uptake of influenza vaccinations in patients receiving cytotoxic chemotherapy', International Journal of Clinical Practice, 57, pp. 542 - 543
,2003, 'Pseudomyxoma peritonei: The 'controversial' disease', International Journal of Gynecological Cancer, 13, pp. 413 - 418, http://dx.doi.org/10.1046/j.1525-1438.2003.13318.x
,2003, 'A dose-escalating study of oral eniluracil/5-fluorouracil plus oxaliplatin in patients with advanced gastrointestinal malignancies', Annals of Oncology, 14, pp. 864 - 866, http://dx.doi.org/10.1093/annonc/mdg254
,2003, 'Pseudomyxoma peritonei: the ‘controversial’ disease', International Journal of Gynecologic Cancer, 13, pp. 413 - 418, http://dx.doi.org/10.1136/ijgc-00009577-200307000-00003
,2002, 'Influenza vaccination and chemotherapy: A shot in the dark?', Supportive Care in Cancer, 10, pp. 462 - 465, http://dx.doi.org/10.1007/s00520-001-0337-9
,2002, 'Sentinel node biopsy: An in depth appraisal', Critical Reviews in Oncology/Hematology, 44, pp. 45 - 70, http://dx.doi.org/10.1016/S1040-8428(02)00018-5
,2002, 'Quality of life: It's never too late', Journal of Clinical Oncology, 20, pp. 2915 - 2917, http://dx.doi.org/10.1200/JCO.2002.20.13.2915
,2002, 'Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: Time to take stock!', Journal of Clinical Oncology, 20, pp. 1446 - 1448, http://dx.doi.org/10.1200/JCO.2002.20.6.1446
,2002, 'Symptom palliation in advanced oesophageal cancer', Current Therapeutics, 43, pp. 33 - 35
,2002, 'P10. Effect of GFR methodology on carboplatin dosing', Nuclear Medicine Communications, 23, pp. 408 - 408, http://dx.doi.org/10.1097/00006231-200204000-00090
,2001, 'Collecting duct carcinoma of the kidney associated with the sickle cell trait', International Journal of Clinical Practice, 55, pp. 415 - 417
,2001, 'Is there any place for cytotoxic chemotherapy in endometrial cancer?', Best Practice and Research: Clinical Obstetrics and Gynaecology, 15, pp. 447 - 467, http://dx.doi.org/10.1053/beog.2001.0188
,2001, 'Is there quality in clinical benefit?', Annals of Oncology, 12, pp. 1191 - 1193, http://dx.doi.org/10.1023/A:1012474308888
,2001, 'Management of small cell lung cancer', Expert Review of Anticancer Therapy, 1, pp. 197 - 210, http://dx.doi.org/10.1586/14737140.1.2.197
,2000, 'Varicella-zoster infection after allogeneic bone marrow transplantation: Incidence, risk factors and prevention with low-dose aciclovir and ganciclovir', Bone Marrow Transplantation, 25, pp. 657 - 664, http://dx.doi.org/10.1038/sj.bmt.1702190
,1999, 'An unusual alkaline phosphatase isoenzyme associated with gastric carcinoma', ANNALS OF CLINICAL BIOCHEMISTRY, 36, pp. 743 - 748, http://dx.doi.org/10.1177/000456329903600607
,Conference Papers
2021, 'Modelling the societal outcomes of immunotherapy in cancer care in Australia', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 66 - 66, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'GERIATRIC ONCOLOGY IN THE INSTAGRAM ERA: PHOTOVOICE TO ENABLE PATIENT-CENTERED CARE AND SHARED DECISION MAKING', in INNOVATION IN AGING, OXFORD UNIV PRESS, pp. 26 - 26, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000842009900094&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'ELderly Functional Index (ELFI): Validation of a self-reported measure of functional status in cancer patients.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368307097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Identifying biomarkers to guide immunotherapy treatment of cancer of unknown primary.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368305219&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Avelumab treatment of metastatic merkel cell carcinoma (mMCC): Updated findings from Australian patients enrolled in an expanded access program(EAP)', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 184 - 184, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400298&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Exercise and androgen deprivation therapy: Current practice and future direction at a regional cancer centre', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 198 - 198, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400328&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Feasibility of the electronic rapid fitness assessment (eRFA) in an Australian regional cancer centre', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 194 - 194, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400320&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Modelling the health outcomes of immuno-oncology therapies in cancer care in Australia', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 151 - 152, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'ATHENA (GOG-3020/ENGOT-ov45): A randomised, double-blind, placebo-controlled, phase 3 study of rucaparib plus nivolumab following front-line platinum-based chemotherapy in ovarian cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 196 - 196, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200343&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Avelumab treatment of Australian patients with metastatic Merkel cell carcinoma (mMCC): Experience from an expanded access program (EAP)', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 173 - 174, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200294&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Safe Delivery of Immunotherapy: A Private Cancer Physician's Perspective', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 88 - 89, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'FIRST-LINE CHEMOTHERAPY FOR EPITHELIAL OVARIAN CANCER: A NATIONAL APPROACH TO GUIDELINE RECOMMENDATIONS TO ENCOURAGE BEST PRACTICE', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, pp. 229 - 229, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966500182&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'CIRCULATING BIOMARKERS AND OUTCOMES IN A PHASE 2 TRIAL OF FIRST-LINE EVEROLIMUS ALTERNATING WITH SUNITINIB FOR ADVANCED RENAL CELL CARCINOMA (ANZUP 0901-THE EVERSUN TRIAL)', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, pp. E65 - E65, http://dx.doi.org/10.1016/j.ejca.2014.03.245
,2014, 'Circulating biomarkers and outcomes in a single-arm phase II trial of first-line sunitinib alternating with everolimus for advanced renal cell carcinoma (aRCC): EVERSUN ANZUP trial 0901', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Genitourinary Cancers Symposium, CA, San Francisco, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.428
,2014, 'EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (aRCC) (ANZUP trial 0901)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Genitourinary Cancers Symposium, CA, San Francisco, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.438
,2013, 'INTRODUCING THE NURSE PRACTITIONER ROLE TO IMPROVE REGIONAL ONCOLOGY PATIENT OUTCOMES', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 136 - 136, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800241&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'OVARIAN CANCER IN THE ELDERLY - THE ROLE OF SURGERY AND SYSTEMIC TREATMENT', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 67 - 67, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'PRACTICE PEARLS: WHAT IS DIFFERENT WHEN DEALING WITH THE OLDER PATIENT? A MEDICAL ONCOLOGIST'S PERSPECTIVE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 62 - 62, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'SURVIVAL OF AUSTRALIAN WOMEN WITH EPITHELIAL OVARIAN CANCER - A POPULATION-BASED STUDY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 81 - 81, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800072&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,